Skip to main content
OpenTrials
Completed

NCT Number: NCT03791320

Fast Assessment of STenosis Severity- FASTII Study

The Multicenter FAST (Fast Assessment of STenosis severity) study is a prospective observational multicenter study designed to evaluate the diagnostic accuracy of offline 3D-QCA based FFR, using CAAS Workstation (Pie Medical Imaging, Maastricht, the Netherlands) in identifying hemodynamically significant coronary artery disease with pressure wire-based FFR (≤0.80) as the reference standard.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU, Lille, France

Loading trial locations.

About this study

The Multicenter FAST study is a prospective observational multicenter international study in which offline computation of vFFR is compared to conventional invasive, wire based FFR measurements. Pressure wire based FFR will be performed in patients with at least one intermediate coronary lesion at the discretion of the operator (typically defined as a coronary artery lesion with a diameter stenosis of 30-70% by visual assessment). A total of 3 two-dimensional angiography images, will be recorded and exported to the CAAS workstation 8.0 (Pie Medical Imaging, Maastricht, the Netherlands): two orthogonal views to create a 3D reconstruction of the coronary arteries and one view to ascertain the position of the FFR pressure wire. vFFR will be calculated automatically, by using the invasively measured aortic root pressure. vFFR measurements will be performed online by the different centers. In addition, all angiographic imaging data will be sent to an independent core laboratory (Cardialysis, Rotterdam, The Netherlands) for offline analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients ≥ 18 years
  • indication procedure: stable, unstable angina or non-ST elevation acute coronary syndrome
  • Diagnostic coronary angiography or PCI with an indication to perform re-PCI FFR assessment of at least one coronary artery lesion.

Exclusion criteria

  • ST-elevation myocardial infarction (STEMI)
  • Cardiogenic shock
  • Severe hemodynamic instability
  • Adenosine intolerance
  • Lesions containing thrombus, left main lesions, grafts, arteries with collaterals

Treatment and study plan

vessel Fractional Flow Reserve

Diagnostic Test

FFR measurement based on coronary angiography

Other names: 3D-QCA based FFR

Primary outcomes

  1. Diagnostic accuracy of vFFR to identify FFR (≤0.8 or >0.8) calculated by corelab

    Time frame: 1 year

    The diagnostic accuracy of offline vFFR assessed by a blinded independent core laboratory to identify hemodynamically-significant coronary stenosis with FFR (≤0.8 or >0.8) as the reference standard.

Secondary outcomes

  1. Diagnostic accuracy of vFFR to identify FFR (≤0.8 or >0.8) calculated by site/operator

    Time frame: 1 year

    The diagnostic accuracy of operator or cathlab technician calculated online vFFR to identify hemodynamically-significant coronary stenosis with FFR (≤0.8 or >0.8) as the reference standard.

  2. Interobserver variability

    Time frame: 1 year

    3D-QCA based FFR (vFFR) will be calculated twice: by the operator/technician of different centers AND by an independent corelab (Cardoalysis). Correlation and agreement between these two measurements will be assessed in order to investigate the Inter-observer variability.

Sponsors and collaborators

Lead sponsor

Erasmus Medical Center

Other

Collaborators

  • Centro Cardiologico Monzino
  • Columbia University
  • Tokyo Medical University
  • University Hospital Carl Gustav Carus
  • University Hospital, Lille

Registry information

Official study title

Multicenter Validation of 3D-QCA Based FFR vs. Pressure Wire Based FFR: The FAST-II Study

Acronym: FASTII

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jan 2, 2019
Registry last updated
Dec 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.